CompletedPhase 2NCT04774874

A Phase 2a Trial of FOL-005 Topical Formulations to Investigate Hair Growth Potential and Safety in Healthy Male Volunteers

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Follicum AB
Principal Investigator
Ulrike Blume-Peytavi
Klinik für Dermatologie, Charité-Universitätsmedizin, Berlin
Intervention
Topical formulation(drug)
Enrollment
209 target
Eligibility
18-55 years · MALE
Timeline
20202021

Study locations (1)

Collaborators

proDERM GmbH · Hair and Skin Institute, Charité, Berlin, Germany · CentroDerm GmbH

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04774874 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials